Biotricity (BTCY) Stock Statistics & Valuation Metrics

Biotricity has a market cap or net worth of $9.47M. The enterprise value is $43.14M.

Biotricity has 24,751,757 shares outstanding. The number of shares has decreased by -2.65% in one year.

Biotricity’s return on equity (ROE) is 0.47 and return on invested capital (ROIC) is 189.35%.

The current PE Ratio of Biotricity is -0.91. Biotricity’s PEG ratio is 0.03.

In the last 12 months, Biotricity had revenue of 12.06M and earned -14.09M in profits. Earnings per share was -1.66.

In the last 12 months, operating cash flow was -3.15M and capital expenditures 0.00, giving a free cash flow of -3.15M billion.

Biotricity pays an annual dividend of ―, resulting in a dividend yield of ―

Biotricity upcoming earnings date is Jun 27, 2025, Before Open (Confirmed).

Biotricity as a current ratio of 0.20, with Debt / Equity ratio of -98.49%

In the past 12 months, Biotricity has paid 0.00 in taxes.

Biotricity EV to EBITDA ratio is -4.04, with an EV/FCF ratio of -5.37.

Biotricity has $509.60K in cash and marketable securities with $25.46M in debt, giving a net cash position of $24.95M billion.

Gross margin is 56.46%, with operating margin of -73.18%, and net profit margin of -116.84%.

The average price target for Biotricity is ―, which is 11.43% higher than the current price. The consensus rating is Hold